SECURITIES AND EXCHANGE COMMISSION 

Washington, D.C. 20549 

FORM 8K 

CURRENT REPORT 

Pursuant to Section 13 or 15(d) of the 

Securities Exchange Act of 1934 

Date of Report (Date of earliest event reported) March 1, 2017 

Cigna Corporation 

(Exact name of registrant as specified in its charter) 

  [DATA_TABLE_REMOVED] 

900 Cottage Grove Road 

Bloomfield, Connecticut 06002 

(Address of principal executive offices) (Zip Code) 

Registrant's telephone number, including area code: 

(860) 226-6000 

Not Applicable 

(Former name or former address, if changed since last report) 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: 

[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) 

[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) 

[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) 

[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) 

Item 7.01 Regulation FD Disclosure. 

Cigna Corporation ("Cigna") previously announced its intention to host an Investor Day on March 29, 2017. In light of the recently announced schedule in the appeal of the U.S. District Court's ruling to enjoin the proposed merger with Anthem, Cigna has decided to postpone its Investor Day to a later date. Cigna will provide further details when available, and continues to look forward to the Investor Day discussion of its strategic growth plan as well as its plans for future capital deployment. 

SIGNATURE 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. 

 [DATA_TABLE_REMOVED]